相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis
Yuxiang Hu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
IL-37 Represses the Autoimmunity in Myasthenia Gravis via Directly Targeting Follicular Th and B Cells
Zhuo Liu et al.
JOURNAL OF IMMUNOLOGY (2020)
Rituximab in AChR subtype of myasthenia gravis: systematic review
Vincenzo Di Stefano et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS
Merve Cebi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial
Siegfried Kohler et al.
BMJ OPEN (2019)
Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis
Sisi Jing et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis
Jose A. Villegas et al.
JOURNAL OF AUTOIMMUNITY (2019)
Immunotherapy in myasthenia gravis in the era of biologics
Marinos C. Dalakas
NATURE REVIEWS NEUROLOGY (2019)
B Cell Immunophenotyping and Transcriptional Profiles of Memory B Cells in Patients with Myasthenia Gravis
Young Gi Min et al.
EXPERIMENTAL NEUROBIOLOGY (2019)
An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients
Jose Adolfo Villegas et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis
Karen Hewett et al.
NEUROLOGY (2018)
High Frequency of Tc22 and Th22 Cells in Myasthenia Gravis Patients and Their Significant Reduction after Thymectomy
Behrouz Robat-Jazi et al.
NEUROIMMUNOMODULATION (2018)
Regulatory B cells in myasthenia gravis are differentially affected by therapies
Vuslat Yilmaz et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
REMISSION OF MYASTHENIA GRAVIS WITH MuSK Antibodies During Ruxolitinib Treatment
Paolo E. Alboini et al.
MUSCLE & NERVE (2017)
A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells
Masayuki Homma et al.
NEUROTHERAPEUTICS (2017)
Memory B cell resurgence requires repeated rituximab in myasthenia gravis
Kohei Muto et al.
NEUROMUSCULAR DISORDERS (2017)
Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab
Dagur Ingi Jonsson et al.
NEUROMUSCULAR DISORDERS (2017)
Significance of B10 cell in patients with thymoma complicated with myasthenia gravis
Yang Lu et al.
ONCOTARGET (2017)
Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models
Marieke Robinet et al.
FRONTIERS IN IMMUNOLOGY (2017)
B10 cell Frequencies and suppressive capacity in Myasthenia gravis are associated with Disease severity
John S. Yi et al.
FRONTIERS IN NEUROLOGY (2017)
Regulatory B Cells in Seropositive Myasthenia Gravis versus Healthy Controls
Md Rezaul Karim et al.
FRONTIERS IN NEUROLOGY (2017)
Increased expression of P2X7 receptor in peripheral blood mononuclear cells correlates with clinical severity and serum levels of Th17-related cytokines in patients with myasthenia gravis
Yong Zhang et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2017)
CD4+ FoxP3+ T regulatory cell subsets in myasthenia gravis patients
Siegfried Kohler et al.
CLINICAL IMMUNOLOGY (2017)
Follicular Helper T Cells
Carola G. Vinuesa et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Phenotypical characterization of regulatory T cells in humans and rodents
A. L. Rodriguez-Perea et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Elevated plasma interleukin-17A in a subgroup of Myasthenia Gravis patients
Yanchen Xie et al.
CYTOKINE (2016)
T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis
Patrick Blanco et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production
Yonghao Cao et al.
JOURNAL OF IMMUNOLOGY (2016)
Augmentation of Circulating Follicular Helper T Cells and Their Impact on Autoreactive B Cells in Myasthenia Gravis
Cun-Jin Zhang et al.
JOURNAL OF IMMUNOLOGY (2016)
Impaired regulatory B cells in myasthenia gravis
Jian Rong Sheng et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
B-CELL-ACTIVATING FACTOR IS ELEVATED IN SERUM OF PATIENTS WITH MYASTHENIA GRAVIS
Sa-Yoon Kang et al.
MUSCLE & NERVE (2016)
Changes in inflammatory cytokine networks in myasthenia gravis
Akiyuki Uzawa et al.
SCIENTIFIC REPORTS (2016)
Increased frequency of thymic T follicular helper cells in myasthenia gravis patients with thymoma
Yang Song et al.
Journal of Thoracic Disease (2016)
Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence
Xiaoyan Zhang et al.
MOLECULAR NEUROBIOLOGY (2016)
TIPE2 Play a Negative Role in TLR4-Mediated Autoimmune T Helper 17 Cell Responses in Patients with Myasthenia Gravis
Yong Zhang et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Increased serum peroxiredoxin 5 levels in myasthenia gravis
Akiyuki Uzawa et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Association of circulating follicular helper T cells with disease course of NMO spectrum disorders
Yu-Jing Li et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Regulatory function of CD4(+)CD25(++) T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity
Mandi Alahgholi-Hajibehzad et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Myasthenia gravis: subgroup classification and therapeutic strategies
Nils Erik Gilhus et al.
LANCET NEUROLOGY (2015)
Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK
Vuslat Yilmaz et al.
PLOS ONE (2015)
Versatile functions for IL-6 in metabolism and cancer
Jan Mauer et al.
TRENDS IN IMMUNOLOGY (2015)
FOXP3+ Treg cells and gender bias in autoimmune diseases
Jia Nie et al.
FRONTIERS IN IMMUNOLOGY (2015)
B cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis
Vuslat Yilmaz et al.
AUTOIMMUNITY (2015)
Serum high mobility group box 1 is upregulated in myasthenia gravis
Akiyuki Uzawa et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis
Jeffrey T. Guptill et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Serum cytokine and chemokine profiles in patients with myasthenia gravis
A. Uzawa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: Roles of IL-17 and TNF-α
Angeline Gradolatto et al.
JOURNAL OF AUTOIMMUNITY (2014)
Central role of interferon-beta in thymic events leading to myasthenia gravis
Perrine Cufi et al.
JOURNAL OF AUTOIMMUNITY (2014)
Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis
Y. Li et al.
NEUROLOGICAL SCIENCES (2014)
The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
Fabien B. Vincent et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Impaired regulatory function in circulating CD4+CD25highCD127low/- T cells in patients with myasthenia gravis
Muthusamy Thiruppathi et al.
CLINICAL IMMUNOLOGY (2012)
Th17 cell-derived IL-17 is dispensable for B cell antibody production
Akiko Shibui et al.
CYTOKINE (2012)
Changes of Treg-Associated Molecules on CD4+CD25+Treg Cells in Myasthenia Gravis and Effects of Immunosuppressants
Wen-Hua Xu et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Long-lasting treatment effect of rituximab in MuSK myasthenia
J. Diaz-Manera et al.
NEUROLOGY (2012)
T Helper Type 17 Cells Expand in Patients with Myasthenia-Associated Thymoma
Z. Wang et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)
Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis
Revital Aricha et al.
JOURNAL OF AUTOIMMUNITY (2011)
Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis
Alejandro M. Gomez et al.
JOURNAL OF IMMUNOLOGY (2011)
INCREASED SERUM INTERLEUKIN-17 LEVELS IN PATIENTS WITH MYASTHENIA GRAVIS
Jose C. Roche et al.
MUSCLE & NERVE (2011)
IL-6: Regulator of Treg/Th17 balance
Akihiro Kimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Clinical implications of the type 1/type 2 balance of helper T cells and P-glycoprotein function in peripheral T lymphocytes of myasthenia gravis patients
Masayuki Masuda et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients
Masayuki Masuda et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis
J. -H. Yeh et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Decrease of CD4+CD25highFoxp3+ regulatory T cells and elevation of CD19+BAFF-R+ B cells and soluble ICAM-1 in myasthenia gravis
Xiang Li et al.
CLINICAL IMMUNOLOGY (2008)
Thymopoiesis, regulatory t cells, and TCRVβ expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy
Andrea Fattorossi et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas
S. Scarpino et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Myasthenia gravis: past, present, and future
Bianca M. Conti-Fine et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients
Y Suzuki et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients
R Saito et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma
C Luther et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Selective loss of regulatory T cells in thymomas
P Ströbel et al.
ANNALS OF NEUROLOGY (2004)
分享论文
